Application 016324

Type
NDA
Sponsor
SEBELA IRELAND LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001IMURANAZATHIOPRINETABLET;ORAL50MGYesYes
002IMURANAZATHIOPRINETABLET;ORAL25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
54766-590IMURANazathioprineSebela Pharmaceuticals Inc.NDACurrent
65483-590IMURANazathioprinePrometheus Laboratories Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
79050SUPPL 2024-07-11
79034SUPPL 2024-07-10
57004SUPPL2018-12-21
56943SUPPL2018-12-21
50509SUPPL2017-11-27
12990SUPPL2014-02-11
33164SUPPL2014-02-07
12989SUPPL2011-05-26
441SUPPL2011-05-26
33163SUPPL2011-05-25
10886SUPPL2011-05-25
12988SUPPL2008-07-14
10885SUPPL2008-07-10
33162SUPPL2005-07-29
12987SUPPL2005-07-29
440SUPPL2004-06-07